Geode Capital Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 682,816 shares of BCLI stock, worth $867,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
682,816
Previous 484,285 40.99%
Holding current value
$867,176
Previous $164,000 4.27%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$0.22 - $0.42 $43,676 - $83,383
198,531 Added 40.99%
682,816 $157,000
Q2 2024

Aug 09, 2024
BUY
$0.34 - $0.74 $43,262 - $94,160
127,244 Added 35.64%
484,285 $164,000
Q4 2023

Feb 13, 2024
BUY
$0.15 - $0.4 $6,939 - $18,505
46,264 Added 14.89%
357,041 $96,000
Q3 2023

Nov 13, 2023
BUY
$0.2 - $2.08 $7,014 - $72,947
35,071 Added 12.72%
310,777 $62,000
Q1 2023

May 15, 2023
BUY
$1.43 - $3.3 $2,860 - $6,600
2,000 Added 0.73%
275,706 $909,000
Q4 2022

Feb 13, 2023
SELL
$1.37 - $4.42 $4,014 - $12,950
-2,930 Reduced 1.06%
273,706 $448,000
Q3 2022

Nov 14, 2022
BUY
$2.55 - $4.42 $1,853 - $3,213
727 Added 0.26%
276,636 $1.22 Million
Q2 2022

Aug 12, 2022
SELL
$2.71 - $3.6 $20,530 - $27,273
-7,576 Reduced 2.67%
275,909 $761,000
Q1 2022

May 13, 2022
BUY
$2.92 - $4.19 $15,721 - $22,558
5,384 Added 1.94%
283,485 $952,000
Q4 2021

Feb 11, 2022
BUY
$2.81 - $4.23 $6,606 - $9,944
2,351 Added 0.85%
278,101 $1.11 Million
Q3 2021

Nov 12, 2021
BUY
$3.14 - $4.09 $33,321 - $43,403
10,612 Added 4.0%
275,750 $909,000
Q2 2021

Aug 13, 2021
SELL
$3.01 - $4.01 $641,491 - $854,611
-213,120 Reduced 44.56%
265,138 $1.01 Million
Q1 2021

May 12, 2021
BUY
$3.46 - $7.88 $250,279 - $569,999
72,335 Added 17.82%
478,258 $1.83 Million
Q4 2020

Feb 12, 2021
BUY
$3.99 - $17.73 $24,007 - $106,681
6,017 Added 1.5%
405,923 $1.84 Million
Q3 2020

Nov 13, 2020
BUY
$11.19 - $16.92 $71,436 - $108,017
6,384 Added 1.62%
399,906 $6.77 Million
Q2 2020

Aug 13, 2020
BUY
$4.42 - $12.66 $989,801 - $2.84 Million
223,937 Added 132.05%
393,522 $4.41 Million
Q1 2020

May 14, 2020
BUY
$4.01 - $8.88 $105,659 - $233,979
26,349 Added 18.4%
169,585 $786,000
Q3 2019

Nov 12, 2019
BUY
$3.54 - $4.48 $39,552 - $50,055
11,173 Added 8.46%
143,236 $558,000
Q2 2019

Aug 14, 2019
BUY
$3.59 - $4.3 $96,176 - $115,197
26,790 Added 25.45%
132,063 $521,000
Q2 2018

Aug 14, 2018
BUY
$3.12 - $5.19 $61,036 - $101,531
19,563 Added 22.82%
105,273 $410,000
Q2 2017

Aug 14, 2017
BUY
N/A
85,710
85,710 $356,000

Others Institutions Holding BCLI

# of Institutions
41
Shares Held
10.8M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $46.3M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email